Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas John Dietz currently holds 152,500 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas John Dietz has been a net buyer of EIGR stock. They have purchased $370.4K and sold $124.4K worth of shares.
Thomas John Dietz's most recent insider trade was on Mar 13, 2026, when they sold 104,500 shares at $0.00 per share.
Thomas John Dietz serves as Executive at Eiger BioPharmaceuticals, Inc. (EIGR). They have executed 31 insider transactions totaling $494.7K over their tenure at the company.
Thomas John Dietz holds the position of Executive at Eiger BioPharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Thomas John Dietz has shown a buying trading pattern, with $370.4K in total purchases and $124.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas John Dietz was on Jan 23, 2023, when they purchased $71.5K worth of EIGR shares. This transaction involved 50,000 shares at $1.43 per share.
Thomas John Dietz currently owns 152,500 shares of Eiger BioPharmaceuticals, Inc. (EIGR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas John Dietz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas John Dietz has 31 Form 4 filings on record as an insider at Eiger BioPharmaceuticals, Inc..
Set alerts for Thomas John Dietz and 40,000+ other insiders.